Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin.
Zhang H, Li Y, Lin TY, Xiao K, Haddad AS, Henderson PT, Jonas BA, Chen M, Xiao W, Liu R, Lam KS, Pan CX.
Zhang H, et al. Among authors: liu r.
Nanomedicine (Lond). 2014;9(12):1807-20. doi: 10.2217/nnm.14.44. Epub 2014 Mar 17.
Nanomedicine (Lond). 2014.
PMID: 24628688
Free PMC article.